ClinConnect ClinConnect Logo
Search / Trial NCT06464224

Extremes of Respiratory Effort in Weaning Failure From Mechanical Ventilation: a Prospective Observational Study

Launched by UNIVERSIDADE FEDERAL DO RIO DE JANEIRO · Jun 12, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Respiratory Drive Respiratory Effort

ClinConnect Summary

This clinical trial is studying the challenges some patients face when trying to stop using a breathing machine called mechanical ventilation. Specifically, it looks at how different levels of breathing effort can affect the recovery process for patients who have been on this machine. The researchers want to find out if high levels of breathing effort are linked to difficulties in stopping the use of the machine, as well as longer hospital stays. This study will take place in two hospitals from January 2024 to July 2026 and involves patients over 18 years old who are on mechanical ventilation and are starting to breathe on their own.

To be eligible for the trial, patients must be admitted to the hospital, be over 18, and have been on mechanical ventilation for less than 7 days. However, those with certain conditions, like severe lung diseases or who are pregnant, cannot participate. If a patient joins the study, they will be closely monitored during the first week of their recovery to gather information about their breathing efforts and overall progress. This trial aims to better understand how to help patients wean off mechanical ventilation more safely and effectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients over 18 years old, admitted to the Glória D'or hospital, undergoing orotracheal intubation and invasive mechanical ventilation, in their first 7 years on spontaneous ventilation, who accept to participate in the study by signing the free and informed consent form (or by their legal responsible).
  • Exclusion Criteria:
  • • Neuromuscular disease;
  • Phrenic nerve injury;
  • MV for less than 24 hours;
  • Previously tracheostomized patient;
  • Age under 18;
  • Use of neuromuscular blocker \> 72h;
  • COPD;
  • Patients with pulmonary fibrosis;
  • Pregnancy;
  • Patient under palliative care;
  • COVID-19 pneumonia;
  • Patients reintubated after extubation in this hospitalization for less than 3 weeks.

About Universidade Federal Do Rio De Janeiro

The Universidade Federal do Rio de Janeiro (UFRJ) is a prestigious higher education institution located in Brazil, renowned for its commitment to academic excellence and research innovation. As a leading sponsor of clinical trials, UFRJ leverages its extensive resources and multidisciplinary expertise to advance medical knowledge and improve patient outcomes. The university fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring rigorous adherence to ethical standards and regulatory compliance. UFRJ is dedicated to contributing to the global scientific community through the development and implementation of cutting-edge clinical research initiatives.

Locations

Rio De Janeiro, , Brazil

Patients applied

0 patients applied

Trial Officials

Bruno Vilaça

Study Chair

manager of Physical Therapy team

Bruno Guimarães

Study Chair

manager of physical therapy team

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported